A comparative evaluation of the effects on postoperative pain of systemic and topical forms of benzydamine hydrochloride after periodontal flap surgery: A randomized controlled clinical trial Effects on postoperative pain of systemic and topical forms of benzidamine hydrochloride
Article Sidebar
Main Article Content
Abstract
Objective: The aim of this study was to evaluate comparatively the topical and systemic forms in the postoperative pain control periodontal flap surgery in spite of the daily dose of benzydamine hydrochloride spray form about one in twenty of the oral dose,.
Materials and Methods: In this randomized trial, the 48 systemic healthy individuals in need double-blind study with periodontal flap surgery were evaluated. Consent, demographic information and periodontal clinical parameters were obtained before surgery and periodontal flap surgery was performed with local anesthesia. The patients who underwent surgery were randomly assigned to two groups. One of the groups was prescribed tablet form of postopertive benzydamine hydrochloride and for the other was spray form as topical application. Postoperative pain was assessed by visual analog scale at 2, 6, 8, 12, 24 and 48 hours.
Results: There was no difference between systemic and topical drug groups in terms of demographic characteristics and periodontal clinical parameters. A statistically significant difference was found between 2 and 6 hours in favor of topical application. (p <0.05), but there was no significant difference in pain intensity at the 8th, 12th, 24th and 48th hours.
Conclusion: Although the topical form of benzydamine hydrochloride was 1/20 lower in postoperative pain control after periodontal flap surgery, it was found to be more effective in the early period compared to the systemic form, but equally effective in the late period. We premierly recommend that topical application should be preferred primarily in the prevention of overdose and toxicity in postoperative pain control after periodontal flap operation.
Downloads
Article Details
Accepted 2020-01-17
Published 2020-01-22
References
Tramer MR, Williams JE, Carroll D, Wiffen PJ, Moore RA, McQuay HJ.Comparing analgesic efficacy of non-steroidal anti-inflammatory drugs given by different routes in acute and chronic pain: A qualitative systematic review.
Rosenow DE, Albrechtsen M, Stolke D. A comparison of patient-controlled analgesia with lornoxicam versus morphine in patients undergoing lumbar disk surgery. Anesth Analg 1998;86:1045-50. (PMID: 9585294)
Schug SA, Merry AF, Acland RH. Treatment principles for the use of opioids in pain of nonmalignant origin. Drugs 1991;42:228-39. (PMID: 1717222)
Griswold DE, Hillegass LM, Breton JJ, Esser KM, Adams JL. “Differentiation in vivo of classical non-steroidal antiinflammatory drugs from cytokine suppressive antiinflammatory drugs and other pharmacological classes using mouse tumour necrosis factor alpha production”. Drugs Exp Clin Res.1993; 19(6): 243-8
Nuutinen LS, Laitinen JO, Salomaki TE. A risk-benefit appraisal of injectable NSAIDs in the management of postoperative pain. Drug Safety 1993;9:380-93. (PMID: 8280405)
Moote C. Eficasy of NSAIDs in the management of postoperative pain. Drugs 1992; 44 Suppl 5:14-29. (PMID: 1284558)
Fanaki NH, El-Nakeeb MA, “Antimicrobial activity of benzydamine, a non-steroid antiinflamatory agent”, J. Chemother., 4, 1992, 347-352
Landry RG, Turnbull RJ, Howley T. Effectiveness of benyzdamine HCl in the treatment of periodental post-surgical patients. Res Clin Forum 1988; 10:105-117.
Mazzarella B, Macarone Palmieri A, Mastronardi P, Spatola R, Lamarca S, De Rosa G, et al. Benzydamine for the prevention of pharyngolaryngeal pathology following tracheal intubation. Int J Tissue React 1987; 9:121-129.
Silness J, Löe H. Periodontal Disease in Pregnancy II. Correlation Between Oral Hygiene and Periodontal Condition. Acta Odontol Scand 1964; 22(1): 121-135.
Löe H, Silness J. Periodontal Disease in Pregnancy I. Prevalence and Severity. Acta Odontol Scand 1963; 21(6): 533-551.
Chapman CR, Casey KL, Dubner R, et al. Pain measurement; an overview. Pain 1985;22:1-31.
Hempel V. Pyrazolones in the treatment of postoperative pain. Agents Actions Suppl 1986; 19:331-7. (PMID: 3463186)
Acar K, Acar H, Demir F, Eti Aslan F. Determining the incidence of postsurgical pain and amount of analgesic use postsurgical pain and analgesic. ACU Sağlık Bil Derg 2016;(2):85-91
Alalwani A, Buhara O, Tüzüm MŞ. Oral health-related quality of life and the use of oral and topical nonsteroidal anti-ınflammatory drugs for pericoronitis. Med Sci Monit. 2019;3;25:9200-9206. doi: 10.12659/MSM.918085.
Cigerim L, Eroglu CN. Comparison of clinical efficacies of preoperatively ınitiated naproxen sodium-codeine phosphate in combination, diclofenac potassium, and benzydamine hydrochloride for pain, edema, and trismus after extraction of ımpacted lower third molar: a randomized double-blind study. J Oral Maxillofac Surg. 2018 Mar;76(3):495-502. doi: 10.1016/j.joms.2017.08.041.
Peeva PM, Veleska DS, Apostolova G, Velickovski B, Koneski F. Local effects of using benzydamine in oral surgery. Apolonia. 2016.
Goswami D, Jain G, Mohod M, Baidya DK, Bhutia O, Roychoudhury A. Randomized controlled trial to compare oral analgesic requirements and patient satisfaction in using oral non-steroidalanti-inflammatorydrugs versus benzydamine hydrochloride oral rinses after mandibular third molar extraction: a pilot study J Dent Anesth Pain Med. 2018 Feb;18(1):19-25. doi: 10.17245/jdapm.2018.18.1.19.
World Health Organization. The rational use of drugs. Report of the conference of experts. Nairobi, 25-29 November 1985. Geneva 1987.
World Health Organization. Revised procedures for updating the WHO Model List of Essential Drugs: a summary of proposals and process, May 2001; EB108/ INF.DOC./2.
World Health Organization. Model List of Essential Medicines. Seventeenth list, Mar 2011.
Maxwell S. Rational prescribing: the principles of drug selection. Clinical Medicine 2009; 9:481–485.
Nettis E, Di Paola R, Napoli G, Ferrannini A, Tursi A. Benzydamine: an alternative nonsteroidal anti‐inflammatory drug in patients with nimesulide‐induced urticaria. Allergy. 2002; 57(5), 442-445.